nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—bile duct cancer	0.894	1	CbGaD
Tetrahydrobiopterin—TPH1—Amine-derived hormones—SLC5A5—bile duct cancer	0.0128	0.136	CbGpPWpGaD
Tetrahydrobiopterin—TH—Amine-derived hormones—SLC5A5—bile duct cancer	0.00733	0.0783	CbGpPWpGaD
Tetrahydrobiopterin—PAH—gall bladder—bile duct cancer	0.0058	0.487	CbGeAlD
Tetrahydrobiopterin—NOS3—Effects of Nitric Oxide—NOS2—bile duct cancer	0.00502	0.0537	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.0032	0.0343	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—GNAS—bile duct cancer	0.00221	0.0236	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—bile duct cancer	0.00208	0.0223	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00178	0.019	CbGpPWpGaD
Tetrahydrobiopterin—PAH—liver—bile duct cancer	0.0017	0.143	CbGeAlD
Tetrahydrobiopterin—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—bile duct cancer	0.00158	0.0169	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—NOS2—bile duct cancer	0.00146	0.0157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—TGFB1—bile duct cancer	0.00146	0.0156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—MMP9—bile duct cancer	0.00134	0.0144	CbGpPWpGaD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—TGFB1—bile duct cancer	0.00134	0.0143	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.0013	0.0139	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bile duct cancer	0.00127	0.0135	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—MMP2—bile duct cancer	0.00126	0.0134	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—FAR2—bile duct cancer	0.00118	0.0126	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP2—bile duct cancer	0.00117	0.0125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—GNAS—bile duct cancer	0.00111	0.0119	CbGpPWpGaD
Tetrahydrobiopterin—TH—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00102	0.0109	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—gall bladder—bile duct cancer	0.001	0.0842	CbGeAlD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.000994	0.0106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.000974	0.0104	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NOS2—bile duct cancer	0.000956	0.0102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bile duct cancer	0.000951	0.0102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—liver—bile duct cancer	0.000929	0.0779	CbGeAlD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—NOS2—bile duct cancer	0.000928	0.00992	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP9—bile duct cancer	0.000876	0.00936	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—FAR2—bile duct cancer	0.000861	0.00921	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP9—bile duct cancer	0.000824	0.00881	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—NOS2—bile duct cancer	0.000812	0.00868	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP2—bile duct cancer	0.000796	0.00851	CbGpPWpGaD
Tetrahydrobiopterin—TH—lymph node—bile duct cancer	0.000791	0.0664	CbGeAlD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.000777	0.00831	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—lymph node—bile duct cancer	0.000712	0.0597	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000679	0.00726	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—FAR2—bile duct cancer	0.000677	0.00723	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.000669	0.00715	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—GNAS—bile duct cancer	0.000642	0.00686	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.00063	0.00674	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—ERBB2—bile duct cancer	0.00063	0.00673	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP9—bile duct cancer	0.000599	0.0064	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000591	0.00631	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NRAS—bile duct cancer	0.000589	0.00629	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL6—bile duct cancer	0.000587	0.00627	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—IDH2—bile duct cancer	0.000575	0.00615	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.000568	0.00608	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—bile duct cancer	0.000559	0.00597	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—EGFR—bile duct cancer	0.000552	0.0059	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NOS2—bile duct cancer	0.000549	0.00587	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—EGFR—bile duct cancer	0.000536	0.00573	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL6—bile duct cancer	0.000512	0.00547	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—KRAS—bile duct cancer	0.000507	0.00542	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—RNF43—bile duct cancer	0.000502	0.00537	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—IDH1—bile duct cancer	0.000495	0.00529	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—EGFR—bile duct cancer	0.000484	0.00517	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000469	0.00502	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—FAR2—bile duct cancer	0.000469	0.00501	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—pancreas—bile duct cancer	0.000463	0.0388	CbGeAlD
Tetrahydrobiopterin—PAH—Disease—IDH1—bile duct cancer	0.000432	0.00462	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000431	0.0046	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—HRAS—bile duct cancer	0.000431	0.0046	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—IDH2—bile duct cancer	0.000421	0.0045	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—bile duct cancer	0.000419	0.00447	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IL6—bile duct cancer	0.000412	0.00441	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	0.000412	0.0044	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—IL6—bile duct cancer	0.000383	0.00409	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.000378	0.00404	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—IDH1—bile duct cancer	0.000362	0.00387	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.000361	0.00386	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—HRAS—bile duct cancer	0.000351	0.00375	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000343	0.00367	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—NRAS—bile duct cancer	0.00034	0.00364	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—ERBB2—bile duct cancer	0.00034	0.00364	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—IDH2—bile duct cancer	0.00033	0.00353	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—SLC5A5—bile duct cancer	0.000326	0.00349	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00031	0.00332	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—liver—bile duct cancer	0.000294	0.0247	CbGeAlD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—KRAS—bile duct cancer	0.000293	0.00313	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00029	0.0031	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—IDH1—bile duct cancer	0.000284	0.00304	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.000276	0.00295	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RNF43—bile duct cancer	0.000274	0.00292	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000269	0.00288	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000264	0.00282	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.000264	0.00282	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GNAS—bile duct cancer	0.000254	0.00271	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.000253	0.0027	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000249	0.00267	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—HRAS—bile duct cancer	0.000249	0.00266	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—GNAS—bile duct cancer	0.000249	0.00266	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—bile duct cancer	0.00024	0.00257	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—SLC5A5—bile duct cancer	0.000239	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	0.000238	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—IL6—bile duct cancer	0.000238	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HGF—bile duct cancer	0.000237	0.00254	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.000236	0.00252	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IDH1—bile duct cancer	0.000235	0.00251	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFBR2—bile duct cancer	0.00023	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—IDH2—bile duct cancer	0.000229	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—lymph node—bile duct cancer	0.000226	0.0189	CbGeAlD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.000223	0.00238	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—IL6—bile duct cancer	0.00022	0.00235	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000218	0.00233	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—SMAD4—bile duct cancer	0.000217	0.00232	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000212	0.00227	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—IDH1—bile duct cancer	0.000197	0.00211	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FAR2—bile duct cancer	0.000192	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RNF43—bile duct cancer	0.000192	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	0.000189	0.00202	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—bile duct cancer	0.000188	0.00201	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC5A5—bile duct cancer	0.000187	0.002	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GNAS—bile duct cancer	0.000185	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NOS2—bile duct cancer	0.000182	0.00194	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000181	0.00193	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	0.000179	0.00191	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NOS2—bile duct cancer	0.000162	0.00173	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	0.000154	0.00165	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	0.000154	0.00164	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GNAS—bile duct cancer	0.000146	0.00156	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—bile duct cancer	0.000136	0.00146	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	0.000131	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC5A5—bile duct cancer	0.00013	0.00139	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	0.000127	0.00135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFBR2—bile duct cancer	0.000125	0.00134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	0.000124	0.00133	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000122	0.0013	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB2—bile duct cancer	0.000122	0.0013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	0.000121	0.00129	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—bile duct cancer	0.000119	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SMAD4—bile duct cancer	0.000118	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RNF43—bile duct cancer	0.000112	0.0012	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	0.000104	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—bile duct cancer	0.000104	0.00111	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GNAS—bile duct cancer	0.000101	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—bile duct cancer	9.96e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TGFB1—bile duct cancer	9.67e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IDH1—bile duct cancer	9.62e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	9.55e-05	0.00102	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—IDH2—bile duct cancer	9.37e-05	0.001	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—bile duct cancer	9.25e-05	0.000989	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—bile duct cancer	8.96e-05	0.000957	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOS2—bile duct cancer	8.81e-05	0.000941	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFBR2—bile duct cancer	8.75e-05	0.000936	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	8.62e-05	0.000922	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFB1—bile duct cancer	8.6e-05	0.000919	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	8.45e-05	0.000904	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNAS—bile duct cancer	8.44e-05	0.000903	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—bile duct cancer	8.43e-05	0.000901	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMAD4—bile duct cancer	8.29e-05	0.000886	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—IDH1—bile duct cancer	8.06e-05	0.000861	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	7.99e-05	0.000854	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—bile duct cancer	7.96e-05	0.000851	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—bile duct cancer	7.96e-05	0.000851	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—bile duct cancer	7.82e-05	0.000836	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—bile duct cancer	7.61e-05	0.000814	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	7.1e-05	0.000759	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—bile duct cancer	6.77e-05	0.000724	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—bile duct cancer	6.62e-05	0.000708	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—bile duct cancer	6.48e-05	0.000693	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—bile duct cancer	6.48e-05	0.000692	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—bile duct cancer	5.42e-05	0.00058	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—bile duct cancer	5.31e-05	0.000568	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR2—bile duct cancer	5.11e-05	0.000546	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—bile duct cancer	5.04e-05	0.000539	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMAD4—bile duct cancer	4.84e-05	0.000517	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—bile duct cancer	4.68e-05	0.0005	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—bile duct cancer	4.64e-05	0.000496	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—bile duct cancer	4.59e-05	0.000491	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—bile duct cancer	4.34e-05	0.000464	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNAS—bile duct cancer	4.13e-05	0.000441	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—bile duct cancer	3.98e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—bile duct cancer	3.69e-05	0.000394	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—bile duct cancer	3.6e-05	0.000385	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—bile duct cancer	3.53e-05	0.000377	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—bile duct cancer	3.53e-05	0.000377	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—bile duct cancer	3.28e-05	0.00035	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—bile duct cancer	3.21e-05	0.000344	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—bile duct cancer	3.04e-05	0.000325	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—bile duct cancer	2.71e-05	0.000289	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—bile duct cancer	2.7e-05	0.000288	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—bile duct cancer	2.58e-05	0.000276	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—bile duct cancer	2.47e-05	0.000264	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—bile duct cancer	2.06e-05	0.00022	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—bile duct cancer	1.91e-05	0.000205	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—bile duct cancer	1.88e-05	0.000201	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—bile duct cancer	1.77e-05	0.00019	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—bile duct cancer	1.51e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—bile duct cancer	1.44e-05	0.000154	CbGpPWpGaD
